UCB's Global Corporate Website
Welcome to UCB in the United States

Jun

24

FINTEPLA® (fenfluramine) Results Examining its Impact in Managing Generalized Tonic-Clonic Seizures in Developmental and Epileptic Encephalopathies Published in Epilepsia

Jun

20

UCB Launches Dravet Syndrome Sound of Profound Moments: Family Video Project

Jun

13

UCB at EULAR 2024: Advancing Science for Rheumatic Conditions with High Unmet Needs

Jun

13

New CIMZIA® data for women living with chronic rheumatic diseases throughout pregnancy, and for people living with RA and high rheumatoid factor levels

Jun

12

UCB to share first presentations of BIMZELX® (bimekizumab-bkzx) two-year data in axial spondyloarthritis and psoriatic arthritis at EULAR 2024

Jun

10

Nicole Watson: Mom, Caregiver, and Best Friend, Shares How Her Daughter Emma, Diagnosed with Dravet Syndrome, Embraces Each Day with Love

May

31

Go Behind The Mystery of Myasthenia Gravis On Myasthenia Gravis Awareness Month

May

31

Empowering the Hidradenitis Suppurativa Community: UCB's Triple Approach

May

23

UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in Moderate-to-Severe Hidradenitis Suppurativa

May

10

Moms Really Can Do It All - Meet Tracy: a Mom, Caregiver, Neuroscientist, and Advocate in the Rare Disease Community